A microarray analysis of potential genes underlying the neurosensitivity of mice to propofol

Anesthesia and Analgesia

Volumn 101, Issue 3, 2005, Pages 697-704

  Lowes, Damon A ^a,c   Galley, Helen F ^a   Lowe, Peter R ^a   Rikke, Brad A ^b   Johnson, Thomas E ^b   Webster, Nigel R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HYPNOTIC SEDATIVE AGENT; PROPOFOL; PROTEIN AWP1; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION REGULATION; GENE LOCATION; GENERAL ANESTHESIA; GENETIC VARIABILITY; LORP1 GENE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGHTING REFLEX; UNINDEXED SEQUENCE;

EID: 23944511866     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000160587.72827.B4     Document Type: Article

References (30)

1. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994;364:607-14.
2. Franks NP, Leib WR. Which molecular targets are most relevant to general anaesthesia? Toxicol Lett 1998;100-101:1-8.
3. Little HL. How has molecular pharmacology contributed to our understanding of the mechanism(s) of general anaesthesia? Pharmacol Ther 1996;69:37-58.
4. McClearn GE, Kakihana R. Selective breeding for ethanol sensitivity: short-sleep and long-sleep mice. In: McClearn GE, Deitrich RA, Erwin VG, eds. Development of animal models as pharmacokinetics tools. PHHS Publ. No. ADM 81-113. Washington, DC: US Government Printing Office, 147-159.
5. Simpson VJ, Rikke BA, Costello JM, et al. Identification of a genetic region in mice that specifies sensitivity to propofol. Anesthesiology 1998;88:379-89.
6. A and glycine receptors. Neurochem Int 1999;34:447-52.
7. Krasowski MD, Harrison NL. General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 1999;55:1278-303.
8. Simpson VJ, Blendov Y. Propofol produces differences in behavior but not chloride channel function between selected lines of mice. Anesth Analg 1996;82:327-31.
9. De Fries JC, Wilson JR, Erwin VG, Peterson DR. LS × SS recombinant inbred strains of mice: initial characterization. Alcohol Clin Exp Res 1989;13:196-200.
10. Christensen SC, Johnson TE, Markel PD, et al. Quantitative trait locus analyses of sleep-times induced by sedative-hypnotics in LSXSS recombinant inbred strains of mice. Alcohol Clin Exp Res 1996;20:543-50.
11. Downing C, Shen EH, Simpson VJ, Johnson TE. Mapping quantitative trait loci mediating sensitivity to etomidate. Mamm Genome 2003;14:367-75.
12. Johnson TE, De Fries JC, Markel PD. Mapping quantitative trait loci for behavioral traits in the mouse. Behav Genet 1992;22: 635-53.
13. Rikke BA, Simpson VJ, Montoliu L, Johnson TE. No effect of albinism on sedative-hypnotic sensitivity to ethanol and anaesthetics. Alcohol Clin Exp Res 2001;25:171-6.
14. Wehner JM, Pounder JI, Parham C, Collins AC. A recombinant inbred strain analysis of sleep-time responses to several sedative-hypnotics. Alcohol Clin Exp Res 1992;16:522-8.
15. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridisation to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-80.
16. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001;98:31-6.
17. Tusher VG, Tibshirani R, Chu G. Significant analysis of microarrays applied to the ionising radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
18. Bakay M, Chen YW, Borup R, et al. Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics 2002;3:4.
19. Yuen T, Wurmbach E, Pfeffer RL, et al. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res 2002;30:e48.
20. Duan W, Sun B, Li TW, et al. Cloning and characterization of AWP1, a novel protein that associates with serine/threonine kinase PRK1 in vitro. Gene 2000;256:113-21.
21. Matsuzawa K, Kosako H, Inagaki N, et al. Domain-specific phosphorylation of vimentin and glial fibrillary acidic protein by PKN. Biochem Biophys Res Commun 1997;234:621-5.
22. Mukai H, Toshimori M, Shibata H, et al. Interaction of PKN with alpha-actinin. J Biol Chem 1997;272:4740-6.
23. Mukai H, Toshimori M, Shibata H, et al. PKN associates and phosphorylates the head-rod domain of neurofilament protein. J Biol Chem 1996;271:9816-22.
24. Smythe E, Ayscough KR. The Ark1/Prk1 family of protein kinases: regulators of endocytosis and the actin cytoskeleton. EMBO Rep 2003;4:246-51.
25. Xu L, Yang L, Hashimoto K, et al. Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with topoisomerase I. BMC Genomics 2002; 3:1.
26. Pisani DF, Cabane C, Derijard B, et al. The topoisomerase 1-interacting protein BTBD1 is essential for muscle cell differentiation. Cell Death Differ 2004;11:1157-65.
27. Kawamata T, Taniguchi T, Mukai H, et al. A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associates endoplasmic reticulum-derived vesicles and phosphorylates tau protein. J Neurosci 1998;18:7402-10.
28. Shibata H, Oda H, Mukai H, et al. Interaction of PKN with neurone-specific base helix-loop-helix transcription factor, NDRF/NeuroD2. Brain Res Mol Brain Res 1999;74:126-34.
29. Wand G, Levine M, Zweifel L, et al. The cAMP-protein kinase A signal transduction pathway modulates ethanol consumption and sedative effects of ethanol. J Neurosci 2001;21:5297-303.
30. Ehringer MA, Thompson J, Conroy O, et al. High-throughput sequence identification of gene coding variants within alcohol-related QTLs. Mamm Genome 2001;12:657-63.